NCT01965470已完成4 期
Botswana Combination Prevention Project: -Evaluation Protocol (Protocol #1): Research Design and Impact Evaluation -Closed Clinical Cohort Protocol (Protocol #3) Implementation, Monitoring and Evaluation of Combination HIV Prevention Interventions in Rural and Peri-Urban Communities in Botswana
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 1
- 主要终点
- Population-level, cumulative HIV incidence
研究概览
简要总结
The BCPP study is designed to test the hypothesis that implementing an enhanced combination prevention package which includes provision of ART to all participants, regardless of CD4 count or HIV disease severity, will impact the HIV/AIDS epidemic by significantly reducing population-level, cumulative HIV incidence in a defined geographic area over a period of 3 years and will be cost-effective.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
入排标准
- 年龄范围
- 16 Years 至 64 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Protocol #1 - Baseline Household Survey (BHS): Permanent or part-time study community resident in any of the 30 study communities; Botswana citizen or spouse of a Botswana citizen; able to provide informed consent if ≥18 years old, or able to provide assent to complement a guardian's permission, if a minor (aged 16 or 17).
- •Protocol #3 - Expanded treatment cohort: HIV-infected persons in Combination Prevention communities who are not yet on ART and are able to provide informed consent if ≥18 years old, or able to provide assent to complement a guardian's permission, if a minor (aged 16 or 17).
排除标准
- •Persons who do not meet inclusion criteria.
结局指标
主要结局
Population-level, cumulative HIV incidence
时间窗: 3 years
Population-level cumulative HIV incidence will be measured in a cohort of HIV-negative persons identified from a 20% sample of eligible households in the 30 study communities followed annually.
次要结局
- 2. Population-level uptake of HIV testing and counseling (HTC), ART, VL Suppression, male circumcision (MC), and PMTCT services(3 years)
- Cost per additional infection averted(3 years)
研究者
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
不适用
Brief Cognitive Behavioral Therapy Replication TrialSuicide, AttemptedSuicidal IdeationNCT03769259University of Utah300
已完成
Unknown
Arita-cho Vascular Endothelial Function StudyONEJPRN-UMIN000051140HuBit genomix,Inc.341
已完成
不适用
Arita-cho Vascular Endothelial Function StudyONEJPRN-UMIN000048118HuBit genomix,Inc.400
已完成
不适用
Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit StimulantsOpiate OverdoseFentanyl OverdoseHarm ReductionNCT05493475Nationwide Children's Hospital653
终止
不适用
Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)RECURRENT GLIOBLASTOMABrain TumorNCT01925573University of Maryland, Baltimore7